Seuraa
Eduardo R. Zimmer
Eduardo R. Zimmer
Assistant Professor, UFRGS
Vahvistettu sähköpostiosoite verkkotunnuksessa ufrgs.br - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Reactive astrocyte nomenclature, definitions, and future directions
C Escartin, E Galea, A Lakatos, JP O’Callaghan, GC Petzold, ...
Nature neuroscience 24 (3), 312-325, 2021
18232021
Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum
AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton, TA Pascoal, F Lussier, ...
JAMA neurology 78 (12), 1471-1483, 2021
3572021
Astrocyte biomarkers in Alzheimer’s disease
SF Carter, K Herholz, P Rosa-Neto, L Pellerin, A Nordberg, ER Zimmer
Trends in molecular medicine 25 (2), 77-95, 2019
3002019
[18F]FDG PET signal is driven by astroglial glutamate transport
ER Zimmer, MJ Parent, DG Souza, A Leuzy, C Lecrux, HI Kim, S Gauthier, ...
Nature neuroscience 20 (3), 393-395, 2017
2962017
Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an in vitro model for Alzheimer’s disease studies
LM de Medeiros, MA De Bastiani, EP Rico, P Schonhofen, B Pfaffenseller, ...
Molecular neurobiology 56, 7355-7367, 2019
2142019
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
B Bellaver, G Povala, PCL Ferreira, JP Ferrari-Souza, DT Leffa, ...
Nature medicine 29 (7), 1775-1781, 2023
1672023
Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography
J Therriault, M Vermeiren, S Servaes, C Tissot, NJ Ashton, AL Benedet, ...
JAMA neurology 80 (2), 188-199, 2023
1412023
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease
NJ Ashton, AL Benedet, TA Pascoal, TK Karikari, J Lantero-Rodriguez, ...
EBioMedicine 76, 2022
1232022
Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
ER Zimmer, A Leuzy, AL Benedet, J Breitner, S Gauthier, P Rosa-Neto
Journal of neuroinflammation 11, 1-12, 2014
1232014
Exercise increases insulin signaling in the hippocampus: physiological effects and pharmacological impact of intracerebroventricular insulin administration in mice
AP Muller, J Gnoatto, JD Moreira, ER Zimmer, CB Haas, F Lulhier, ...
Hippocampus 21 (10), 1082-1092, 2011
1072011
Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis
B Bellaver, JP Ferrari-Souza, L Uglione da Ros, SF Carter, ...
Neurology 96 (24), e2944-e2955, 2021
1022021
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
WS Brum, NC Cullen, S Janelidze, NJ Ashton, ER Zimmer, J Therriault, ...
Nature Aging 3 (9), 1079-1090, 2023
962023
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
JP Ferrari-Souza, PCL Ferreira, B Bellaver, C Tissot, YT Wang, DT Leffa, ...
Molecular psychiatry 27 (11), 4781-4789, 2022
932022
Reduced brain insulin-like growth factor I function during aging
AP Muller, AM Fernandez, C Haas, E Zimmer, LV Portela, I Torres-Aleman
Molecular and Cellular Neuroscience 49 (1), 9-12, 2012
932012
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
AL Benedet, WS Brum, O Hansson, ...
Alzheimer's research & therapy 14 (1), 26, 2022
872022
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer’s disease
AL Benedet, A Leuzy, TA Pascoal, NJ Ashton, S Mathotaarachchi, ...
Brain 143 (12), 3793-3804, 2020
872020
Staging of Alzheimer’s disease: past, present, and future perspectives
J Therriault, ER Zimmer, AL Benedet, TA Pascoal, S Gauthier, ...
Trends in molecular medicine 28 (9), 726-741, 2022
862022
Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates
DM Vargas, MA De Bastiani, ER Zimmer, F Klamt
Alzheimer's Research & Therapy 10, 1-12, 2018
842018
Amyloid‐β oligomers in cellular models of Alzheimer’s disease
IC Fontana, AR Zimmer, AS Rocha, G Gosmann, DO Souza, MV Lourenco, ...
Journal of Neurochemistry 155 (4), 348-369, 2020
822020
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
K Heurling, NJ Ashton, A Leuzy, ER Zimmer, K Blennow, H Zetterberg, ...
Molecular and Cellular Neuroscience 97, 34-42, 2019
782019
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20